✨ Your Portfolio is fetched and updated from zerodha.
Small Chemicals
Market Cap
₹3,823 Cr.
P/E
275.86

Key Ratios

Market cap
Market cap
3,823 Cr
PE
PE
275
Prom Holding
Prom Holding
19.74 %
ROE (%)
ROE (%)
4.40
ROCE (%)
ROCE (%)
7.68
Div Yield (%)
Div Yield (%)
0.03
Sales
Sales
440 Cr
OPM (%)
OPM (%)
8.39 %
Debt to Equity
Debt to Equity
0.19
About
Bhagiradha Chemicals &Inds.Ltd. is into the business of manufacturing high quality basic pesti… Read more
Low
247
52W Range
High
448
  • Bhagiradha Chem
  • NACL Industries
  • Bharat Rasayan

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Custom financial statementNew
Edit rows
Forensics

8 Yes

Positive for this company

2 Neutral

Neutral for this company

7 No

Negative for this company

0 No Data

Insufficient data to analyse

Revenue mix

Product Wise Break-Up

Location Wise Break-Up

Asset Break-Up - Geography Wise

Peer Comparison
Corporate Actions
Consolidated
DATE
DETAILS
Show More
Show Less
Show More
Show Less
Customers
  • Bharat Rasayan Ltd.
  • Dow Agro Sciences (USA)
  • Adama Makthteshim Limited
  • Helm AG (Germany)
FAQs on Bhagiradha Chemicals & Industries Ltd. Business

Bhagiradha Chemicals & Industries Ltd. specializes in manufacturing basic pesticides including Chlorpyrifos Ethyl and Clodinafop-Propargyl Technical. They focus on research and development to improve processes and develop generic processes.

Bhagiradha Chem major competitors are NACL Industries, Bharat Rasayan, Insecticides India, India Pesticides, Meghmani Organics, Rallis India, Astec Lifesciences.
Market Cap of Bhagiradha Chem is ₹3,823 Crs.
While the median market cap of its peers are ₹2,859 Crs.

Bhagiradha Chem seems to be financially stable compared to its competitors.
The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.

Company Filing
2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
Annual Report FY25 FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
Earnings Release
Investor Presentation May Sep Dec
Conference Call
Conference Call SummaryCon Call Summary
Discussions & Analysis
Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material